Global Neurovascular Devices/Interventional Neurology Market : Industry Analysis, Growth, Segmentation and Forecast-2020-2027

The Global Market for Neurovascular Devices/Interventional Neurology was valued $xx Mn in 2020 and is expected to reach $xx Mn by 2027, at a CAGR of xx%.

Global Neurovascular Devices/Interventional Neurology Market introduction and Overview

Neurovascular/interventional neurology devices are used to treat several neurovascular diseases (including aneurysms, arteriovenous malformations and atherosclerosis) that affect the central nervous system as well as the blood vascular system associated with it. Therapeutic procedures are increasingly being adopted for better diagnosis, monitoring and therapy for neurological conditions because of their proven efficacy. This is one of the major reasons for increasing adoption of interventional neurology products. These products are adopted globally by majority of neurosurgeons and medical professionals in key markets such as the U.S, Germany, France and UK. Significant consumption value of neurovascular devices and rapidly growing patient population are expected to boost the market growth. The increasing prevalence of cancers, strokes and other malformations has made the innovation of advanced technologies mandatory. Changing sedentary lifestyle, high blood pressure, smoking, obesity are resulting in rising cases of neurological or neurovascular diseases. According to a country wise analysis, the number of cases of brain aneurysm and ischemic strokes are increasing rapidly in developing as well as developed economies. There is a rise in demand for minimally invasive surgical procedures, also technological advancements in neurovascular treatments are taking place. Moreover, government initiatives to modernize healthcare infrastructure across the globe are also expected to drive the market upwards. All the above mentioned factors are responsible for the Neurovascular Devices/Interventional Neurology Market to grow at a rapid pace in the forecast period. However, the chief markets such as the U.S., Germany, and Japan have a limited number of neurosurgeons with the required skills and experience to perform surgical clipping or endoscopy to treat complex cerebral aneurysms. In terms of providing training, healthcare providers across these markets have been unable to match the ongoing technological advancements and expansion of patient base. Thus, the inadequacy of skilled and experienced neurosurgeons is restraining the adoption of neurovascular devices/interventional neurology. The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Neurovascular Devices/Interventional Neurology Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges. The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

Global Neurovascular Devices/Interventional Neurology Market Segment Analysis

The aneurysm coiling and embolization devices segment is expected to account for the largest market share of xx% in the forecast period. Coil embolization is a minimally invasive procedure to treat an aneurysm by filling it with material that closes off the sac and reduces the risk of bleeding. It is performed from "within" the artery (endovascular) through a steerable catheter inserted into the blood stream at the groin and guided to the brain. The increasing frequency of unruptured intracranial aneurysm detection and rising focus on new product launches are expected to boost the segment growth. Moreover, high demand for minimally invasive neurosurgical procedures and availability of embolic coils are also augmenting the market growth. On the basis of disease pathology, the market is segmented into ischemic strokes, cerebral aneurysm, arteriovenous malfunctions and fistulas and other diseases. The ischemic stroke segment is expected to grow at a highest CAGR of xx% during the forecast period. The growing incidences of ischemic strokes and increasing preference for minimally invasive surgeries by patients, the segment is expected to grow upwards.This type of stroke is caused by a blockage in an artery that supplies blood to the brain. The blockage reduces the blood flow and oxygen to the brain, leading to damage or death of brain cells. Such strokes are treated with minimum invasive procedures such as diagnostic angiography, cerebral balloon angioplasty and stent placement. Global Neurovascular Devices-Interventional Neurology Market To know about the Research Methodology :- Request Free Sample Report

Global Neurovascular Devices/Interventional Neurology Market Segmentation

The market is segmented based on-

Product

• Aneurysm Coiling & Embolization Devices  Embolic coils  Flow diversion devices  Liquid embolic agents • Cerebral Balloon angioplasty and stenting systems • Support devices • Neurothrombectomy devices

Disease Pathology

• Ischemic Strokes • Cerebral Aneurysms • Arteriovenous Malformation and Fistulas • Other Disease pathology

Scope of the report :Inquire before buying

Global Neurovascular Devices/Interventional Neurology Market Regional Insights

Global Neurovascular Devices-Interventional Neurology Market1 North America generated a revenue of $xx Mn in 2020 and is expected to emerge as a dominant region in the forecast period. Increasing prevalence of strokes,rising awareness among neurosurgeons related to the benefits offered by interventional neurology devicesgrowing research activities, advanced treatment techniques and high class healthcare facilities available are boosting the market in the region. Asia Pacific is expected to witness growth in the forecast period. Owing to the increasing population and growing healthcare facilities in developing nations the market in this region is anticipated to grow.

Key Players operating in the Global Neurovascular Devices/Interventional Neurology Market

• Stryker Corporation • Medtronic plc • Johnson & Johnson • Terumo Corporation • Penumbra, Inc • Abbott Laboratories • Merit Medical Systems, Inc • W.L Gore & Associates, Inc • Microport Scientific Corporation • B. Braun Melsungen AG • Cook • Uresil, LLC • Medikit Co Ltd • Bayer AG • Acandis GmbH • Biosensors International group Ltd • Integra Life sciences Corporation • Others The report also helps in understanding Global Neurovascular Devices/Interventional Neurology Marketdynamics, structure by analysing the market segments and project the Global Neurovascular Devices/Interventional Neurology Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Neurovascular Devices/Interventional Neurology Marketmake the report investor’s guide.

Global Neurovascular Devices/Interventional Neurology Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis and Forecast 6.1. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product 7.4. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size (US$ Mn) Forecast, By Product 7.5. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Product 7.6. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis, By Product 8. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis and Forecast, By Disease Pathology 8.1. Introduction and Definition 8.2. Key Findings 8.3. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology 8.4. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size (US$ Mn) Forecast, By Disease Pathology 8.5. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Disease Pathology 8.6. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis, By Disease Pathology 9. Global NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Region 9.1. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Region 9.2. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Size (US$ Mn) Forecast, By Region 9.3. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis, By Region 10. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis 10.1. Key Findings 10.2. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview 10.3. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product 10.4. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 10.4.1. Aneurysm Coiling & Embolization Devices 10.4.2. Cerebral Balloon angioplasty and stenting systems 10.4.3. Support devices 10.4.4. Neurothrombectomy devices 10.5. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology 10.6. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 10.6.1. Ischemic Strokes 10.6.2. Cerebral Aneurysms 10.6.3. Arteriovenous Malformation and Fistulas 10.6.4. Other Disease pathology 10.7. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country 10.8. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country 10.10. U.S. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 10.10.1. Aneurysm Coiling & Embolization Devices 10.10.2. Cerebral Balloon angioplasty and stenting systems 10.10.3. Support devices 10.10.4. Neurothrombectomy devices 10.11. U.S. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 10.11.1. Ischemic Strokes 10.11.2. Cerebral Aneurysms 10.11.3. Arteriovenous Malformation and Fistulas 10.11.4. Other Disease pathology 10.12. Canada NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 10.12.1. Aneurysm Coiling & Embolization Devices 10.12.2. Cerebral Balloon angioplasty and stenting systems 10.12.3. Support devices 10.12.4. Neurothrombectomy devices 10.13. Canada NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 10.13.1. Ischemic Strokes 10.13.2. Cerebral Aneurysms 10.13.3. Arteriovenous Malformation and Fistulas 10.13.4. Other Disease pathology 10.14. Mexico NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 10.14.1. Aneurysm Coiling & Embolization Devices 10.14.2. Cerebral Balloon angioplasty and stenting systems 10.14.3. Support devices 10.14.4. Neurothrombectomy devices 10.15. Mexico NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 10.15.1. Ischemic Strokes 10.15.2. Cerebral Aneurysms 10.15.3. Arteriovenous Malformation and Fistulas 10.15.4. Other Disease pathology 10.16. North America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis 10.16.1. By Product 10.16.2. By Disease Pathology 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis 11.1. Key Findings 11.2. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview 11.3. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product 11.4. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.4.1. Aneurysm Coiling & Embolization Devices 11.4.2. Cerebral Balloon angioplasty and stenting systems 11.4.3. Support devices 11.4.4. Neurothrombectomy devices 11.5. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology 11.6. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.6.1. Ischemic Strokes 11.6.2. Cerebral Aneurysms 11.6.3. Arteriovenous Malformation and Fistulas 11.6.4. Other Disease pathology 11.7. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country 11.8. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.9.1. Aneurysm Coiling & Embolization Devices 11.9.2. Cerebral Balloon angioplasty and stenting systems 11.9.3. Support devices 11.9.4. Neurothrombectomy devices 11.10. Germany NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.10.1. Ischemic Strokes 11.10.2. Cerebral Aneurysms 11.10.3. Arteriovenous Malformation and Fistulas 11.10.4. Other Disease pathology 11.11. U.K. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.11.1. Aneurysm Coiling & Embolization Devices 11.11.2. Cerebral Balloon angioplasty and stenting systems 11.11.3. Support devices 11.11.4. Neurothrombectomy devices 11.12. U.K. NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.12.1. Ischemic Strokes 11.12.2. Cerebral Aneurysms 11.12.3. Arteriovenous Malformation and Fistulas 11.12.4. Other Disease pathology 11.13. France NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.13.1. Aneurysm Coiling & Embolization Devices 11.13.2. Cerebral Balloon angioplasty and stenting systems 11.13.3. Support devices 11.13.4. Neurothrombectomy devices 11.14. France NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.14.1. Ischemic Strokes 11.14.2. Cerebral Aneurysms 11.14.3. Arteriovenous Malformation and Fistulas 11.14.4. Other Disease pathology 11.15. Italy NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.15.1. Aneurysm Coiling & Embolization Devices 11.15.2. Cerebral Balloon angioplasty and stenting systems 11.15.3. Support devices 11.15.4. Neurothrombectomy devices 11.16. Italy NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.16.1. Ischemic Strokes 11.16.2. Cerebral Aneurysms 11.16.3. Arteriovenous Malformation and Fistulas 11.16.4. Other Disease pathology 11.17. Spain NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.17.1. Aneurysm Coiling & Embolization Devices 11.17.2. Cerebral Balloon angioplasty and stenting systems 11.17.3. Support devices 11.17.4. Neurothrombectomy devices 11.18. Spain NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.18.1. Ischemic Strokes 11.18.2. Cerebral Aneurysms 11.18.3. Arteriovenous Malformation and Fistulas 11.18.4. Other Disease pathology 11.19. Sweden NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.19.1. Aneurysm Coiling & Embolization Devices 11.19.2. Cerebral Balloon angioplasty and stenting systems 11.19.3. Support devices 11.19.4. Neurothrombectomy devices 11.20. Sweden NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.20.1. Ischemic Strokes 11.20.2. Cerebral Aneurysms 11.20.3. Arteriovenous Malformation and Fistulas 11.20.4. Other Disease pathology 11.21. CIS countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.21.1. Aneurysm Coiling & Embolization Devices 11.21.2. Cerebral Balloon angioplasty and stenting systems 11.21.3. Support devices 11.21.4. Neurothrombectomy devices 11.22. CIS countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.22.1. Ischemic Strokes 11.22.2. Cerebral Aneurysms 11.22.3. Arteriovenous Malformation and Fistulas 11.22.4. Other Disease pathology 11.23. Rest of Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 11.23.1. Aneurysm Coiling & Embolization Devices 11.23.2. Cerebral Balloon angioplasty and stenting systems 11.23.3. Support devices 11.23.4. Neurothrombectomy devices 11.24. Rest of Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 11.24.1. Ischemic Strokes 11.24.2. Cerebral Aneurysms 11.24.3. Arteriovenous Malformation and Fistulas 11.24.4. Other Disease pathology 11.25. Europe NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis 11.25.1. By Disease Pathology 11.25.2. By Product 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis 12.1. Key Findings 12.2. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview 12.3. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product 12.4. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.4.1. Aneurysm Coiling & Embolization Devices 12.4.2. Cerebral Balloon angioplasty and stenting systems 12.4.3. Support devices 12.4.4. Neurothrombectomy devices 12.5. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology 12.6. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.6.1. Ischemic Strokes 12.6.2. Cerebral Aneurysms 12.6.3. Arteriovenous Malformation and Fistulas 12.6.4. Other Disease pathology 12.7. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country 12.8. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country 12.10. China NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.10.1. Aneurysm Coiling & Embolization Devices 12.10.2. Cerebral Balloon angioplasty and stenting systems 12.10.3. Support devices 12.10.4. Neurothrombectomy devices 12.11. China NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.11.1. Ischemic Strokes 12.11.2. Cerebral Aneurysms 12.11.3. Arteriovenous Malformation and Fistulas 12.11.4. Other Disease pathology 12.12. India NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.12.1. Aneurysm Coiling & Embolization Devices 12.12.2. Cerebral Balloon angioplasty and stenting systems 12.12.3. Support devices 12.12.4. Neurothrombectomy devices 12.13. India NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.13.1. Ischemic Strokes 12.13.2. Cerebral Aneurysms 12.13.3. Arteriovenous Malformation and Fistulas 12.13.4. Other Disease pathology 12.14. Japan NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.14.1. Aneurysm Coiling & Embolization Devices 12.14.2. Cerebral Balloon angioplasty and stenting systems 12.14.3. Support devices 12.14.4. Neurothrombectomy devices 12.15. Japan NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.15.1. Ischemic Strokes 12.15.2. Cerebral Aneurysms 12.15.3. Arteriovenous Malformation and Fistulas 12.15.4. Other Disease pathology 12.16. South Korea NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.16.1. Aneurysm Coiling & Embolization Devices 12.16.2. Cerebral Balloon angioplasty and stenting systems 12.16.3. Support devices 12.16.4. Neurothrombectomy devices 12.17. South Korea NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.17.1. Ischemic Strokes 12.17.2. Cerebral Aneurysms 12.17.3. Arteriovenous Malformation and Fistulas 12.17.4. Other Disease pathology 12.18. Australia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.18.1. Aneurysm Coiling & Embolization Devices 12.18.2. Cerebral Balloon angioplasty and stenting systems 12.18.3. Support devices 12.18.4. Neurothrombectomy devices 12.19. Australia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.19.1. Ischemic Strokes 12.19.2. Cerebral Aneurysms 12.19.3. Arteriovenous Malformation and Fistulas 12.19.4. Other Disease pathology 12.20. ASEAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.20.1. Aneurysm Coiling & Embolization Devices 12.20.2. Cerebral Balloon angioplasty and stenting systems 12.20.3. Support devices 12.20.4. Neurothrombectomy devices 12.21. ASEAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.21.1. Ischemic Strokes 12.21.2. Cerebral Aneurysms 12.21.3. Arteriovenous Malformation and Fistulas 12.21.4. Other Disease pathology 12.22. Rest of Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 12.22.1. Aneurysm Coiling & Embolization Devices 12.22.2. Cerebral Balloon angioplasty and stenting systems 12.22.3. Support devices 12.22.4. Neurothrombectomy devices 12.23. Rest of Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 12.23.1. Ischemic Strokes 12.23.2. Cerebral Aneurysms 12.23.3. Arteriovenous Malformation and Fistulas 12.23.4. Other Disease pathology 12.24. Asia Pacific NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis 12.24.1. By Product 12.24.2. By Disease Pathology 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis 13.1. Key Findings 13.2. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview 13.3. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product 13.4. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 13.4.1. Aneurysm Coiling & Embolization Devices 13.4.2. Cerebral Balloon angioplasty and stenting systems 13.4.3. Support devices 13.4.4. Neurothrombectomy devices 13.5. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology 13.6. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 13.6.1. Ischemic Strokes 13.6.2. Cerebral Aneurysms 13.6.3. Arteriovenous Malformation and Fistulas 13.6.4. Other Disease pathology 13.7. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country 13.8. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country 13.10. GCC Countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 13.10.1. Aneurysm Coiling & Embolization Devices 13.10.2. Cerebral Balloon angioplasty and stenting systems 13.10.3. Support devices 13.10.4. Neurothrombectomy devices 13.11. GCC Countries NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 13.11.1. Ischemic Strokes 13.11.2. Cerebral Aneurysms 13.11.3. Arteriovenous Malformation and Fistulas 13.11.4. Other Disease pathology 13.12. South Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 13.12.1. Aneurysm Coiling & Embolization Devices 13.12.2. Cerebral Balloon angioplasty and stenting systems 13.12.3. Support devices 13.12.4. Neurothrombectomy devices 13.13. South Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 13.13.1. Ischemic Strokes 13.13.2. Cerebral Aneurysms 13.13.3. Arteriovenous Malformation and Fistulas 13.13.4. Other Disease pathology 13.14. Nigeria NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 13.14.1. Aneurysm Coiling & Embolization Devices 13.14.2. Cerebral Balloon angioplasty and stenting systems 13.14.3. Support devices 13.14.4. Neurothrombectomy devices 13.15. Nigeria NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 13.15.1. Ischemic Strokes 13.15.2. Cerebral Aneurysms 13.15.3. Arteriovenous Malformation and Fistulas 13.15.4. Other Disease pathology 13.16. Egypt NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 13.16.1. Aneurysm Coiling & Embolization Devices 13.16.2. Cerebral Balloon angioplasty and stenting systems 13.16.3. Support devices 13.16.4. Neurothrombectomy devices 13.17. Egypt NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 13.17.1. Ischemic Strokes 13.17.2. Cerebral Aneurysms 13.17.3. Arteriovenous Malformation and Fistulas 13.17.4. Other Disease pathology 13.18. Rest of Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 13.18.1. Aneurysm Coiling & Embolization Devices 13.18.2. Cerebral Balloon angioplasty and stenting systems 13.18.3. Support devices 13.18.4. Neurothrombectomy devices 13.19. Rest of Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 13.19.1. Ischemic Strokes 13.19.2. Cerebral Aneurysms 13.19.3. Arteriovenous Malformation and Fistulas 13.19.4. Other Disease pathology 13.20. Middle East & Africa NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis 13.20.1. By Product 13.20.2. By Disease Pathology 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis 14.1. Key Findings 14.2. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Overview 14.3. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Product 14.4. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 14.4.1. Aneurysm Coiling & Embolization Devices 14.4.2. Cerebral Balloon angioplasty and stenting systems 14.4.3. Support devices 14.4.4. Neurothrombectomy devices 14.5. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Disease Pathology 14.6. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 14.6.1. Ischemic Strokes 14.6.2. Cerebral Aneurysms 14.6.3. Arteriovenous Malformation and Fistulas 14.6.4. Other Disease pathology 14.7. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Value Share Analysis, By Country 14.8. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Analysis, By Country 14.10. Brazil NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 14.10.1. Aneurysm Coiling & Embolization Devices 14.10.2. Cerebral Balloon angioplasty and stenting systems 14.10.3. Support devices 14.10.4. Neurothrombectomy devices 14.11. Brazil NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 14.11.1. Ischemic Strokes 14.11.2. Cerebral Aneurysms 14.11.3. Arteriovenous Malformation and Fistulas 14.11.4. Other Disease pathology 14.12. Colombia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 14.12.1. Aneurysm Coiling & Embolization Devices 14.12.2. Cerebral Balloon angioplasty and stenting systems 14.12.3. Support devices 14.12.4. Neurothrombectomy devices 14.13. Colombia NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 14.13.1. Ischemic Strokes 14.13.2. Cerebral Aneurysms 14.13.3. Arteriovenous Malformation and Fistulas 14.13.4. Other Disease pathology 14.14. Argentina NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 14.14.1. Aneurysm Coiling & Embolization Devices 14.14.2. Cerebral Balloon angioplasty and stenting systems 14.14.3. Support devices 14.14.4. Neurothrombectomy devices 14.15. Argentina NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 14.15.1. Ischemic Strokes 14.15.2. Cerebral Aneurysms 14.15.3. Arteriovenous Malformation and Fistulas 14.15.4. Other Disease pathology 14.16. Rest of South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Product 14.16.1. Aneurysm Coiling & Embolization Devices 14.16.2. Cerebral Balloon angioplasty and stenting systems 14.16.3. Support devices 14.16.4. Neurothrombectomy devices 14.17. Rest of South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Forecast, By Disease Pathology 14.17.1. Ischemic Strokes 14.17.2. Cerebral Aneurysms 14.17.3. Arteriovenous Malformation and Fistulas 14.17.4. Other Disease pathology 14.18. South America NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY Market Attractiveness Analysis 14.18.1. By Product 14.18.2. By Disease Pathology 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Disease Pathology, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Disease Pathology 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Stryker Corporation 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Medtronic plc 15.3.3. Johnson & Johnson 15.3.4. Terumo Corporation 15.3.5. Penumbra, Inc 15.3.6. Abbott Laboratories 15.3.7. Merit Medical Systems, Inc 15.3.8. W.L Gore & Associates, Inc 15.3.9. Microport Scientific Corporation 15.3.10. B. Braun Melsungen AG 15.3.11. Cook 15.3.12. Uresil, LLC 15.3.13. Medikit Co Ltd 15.3.14. Bayer AG 15.3.15. Acandis GmbH 15.3.16. Biosensors International group Ltd 15.3.17. Integra Life sciences Corporation 15.3.18. Others

About This Report

Report ID 83403
Category Healthcare
Published Date Feb 2021
Updated Date
Contact Us